The article discusses a human antibody produced by plants called a plantibody, focusing on Mapp Biopharmaceutical's experimental drug for treating Ebola virus disease that incorporates antibodies made by tobacco plants, called ZMapp, and the process of plantibody production.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados